PWA
VCYT icon

Physician Wealth Advisors’s Veracyte VCYT Stock Holding History

Physician Wealth Advisors’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-31
Closed -$838 – 2060
2025
Q2 		$838 Buy
+31
New +$898 ﹤0.01% 1535

Other funds holding VCYT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Physician Wealth Advisors's VCYT Position: Q3 2025 in Review

Physician Wealth Advisors sold out of Veracyte (VCYT) in Q3 2025, closing a stake of 31 shares — an estimated $838 sold.

Physician Wealth Advisors first reported a position in VCYT in Q2 2025 and held it in 1 quarter. The position peaked at $838 in Q2 2025. 298 funds tracked by Wall St. Rank hold VCYT as of Q3 2025.

  • Physician Wealth Advisors reported no remaining Veracyte position as of Q3 2025 after selling out during the quarter.
  • Physician Wealth Advisors sold 31 Veracyte shares in Q3 2025, an estimated $838.
  • Physician Wealth Advisors first reported a position in Veracyte in Q2 2025 and held it in 1 quarter.
  • Physician Wealth Advisors's Veracyte position peaked at $838 in Q2 2025.
  • 298 funds tracked by Wall St. Rank held Veracyte as of Q3 2025.

Based on Physician Wealth Advisors's 13F filing for Q3 2025, filed 4 Nov 2025.